Estimated antiretroviral therapy coverage among people living with HIV in Mus
Mus: Estimated antiretroviral therapy coverage among people living with HIV was 36.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Mus, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among people living with hiv in Mus is 36.0%, measured in 2025. That is the highest value across all 26 years on record.
The figure is up 16.1% on the previous year and up 50.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Mus peaked at 36.0% in 2025 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Mus, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 1.0% | — |
| 2002 | 1.0% | +0.0% |
| 2003 | 1.0% | +0.0% |
| 2004 | 2.0% | +100.0% |
| 2005 | 3.0% | +50.0% |
| 2006 | 4.0% | +33.3% |
| 2007 | 5.0% | +25.0% |
| 2008 | 6.0% | +20.0% |
| 2009 | 6.0% | +0.0% |
| 2010 | 7.0% | +16.7% |
| 2011 | 15.0% | +114.3% |
| 2012 | 16.0% | +6.7% |
| 2013 | 18.0% | +12.5% |
| 2014 | 23.0% | +27.8% |
| 2015 | 24.0% | +4.3% |
| 2016 | 24.0% | +0.0% |
| 2017 | 25.0% | +4.2% |
| 2018 | 26.0% | +4.0% |
| 2019 | 27.0% | +3.8% |
| 2020 | 28.0% | +3.7% |
| 2021 | 29.0% | +3.6% |
| 2022 | 30.0% | +3.4% |
| 2023 | 30.0% | +0.0% |
| 2024 | 31.0% | +3.3% |
| 2025 | 36.0% | +16.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.9% | 0.0% | 6.0% | 10 |
| 2010s | 20.5% | 7.0% | 27.0% | 10 |
| 2020s | 30.7% | 28.0% | 36.0% | 6 |
Countries ranked near Mus
More health data for Mus
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Pertussis - number of reported cases, gaps filled 0 (2025)
- Pertussis - number of reported cases, annual growth rate -100 % change on previous year (2011)
- Pertussis - number of reported cases 0 (2025)
- Total tetanus - number of reported cases 0 (2025)
- Diphtheria - number of reported cases 0 (2025)
- Measles - number of reported cases 0 (2025)
- Neonatal tetanus - number of reported cases 0 (2025)
- Number of under-five deaths 181 (2024)
- Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) 54.3% (2024)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Mus?
- Estimated antiretroviral therapy coverage among people living with hiv in Mus was 36.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Mus?
- The highest recorded value was 36.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Mus?
- The lowest recorded value was 0.0% in 2000.
- How does Mus rank for estimated antiretroviral therapy coverage among people living with hiv?
- Mus ranks 2nd out of 2 regions with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Mus?
- Over the last ten years it is up 50.0%. The long-run trend across the full record is volatile.
- Where does this Mus data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).